Advertisement
UK markets close in 6 hours 53 minutes
  • FTSE 100

    8,112.68
    +33.82 (+0.42%)
     
  • FTSE 250

    19,801.77
    +199.79 (+1.02%)
     
  • AIM

    755.95
    +2.83 (+0.38%)
     
  • GBP/EUR

    1.1654
    -0.0002 (-0.02%)
     
  • GBP/USD

    1.2527
    +0.0016 (+0.13%)
     
  • Bitcoin GBP

    51,372.82
    +363.12 (+0.71%)
     
  • CMC Crypto 200

    1,390.07
    -6.46 (-0.46%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CRUDE OIL

    83.74
    +0.17 (+0.20%)
     
  • GOLD FUTURES

    2,357.90
    +15.40 (+0.66%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,053.19
    +135.91 (+0.76%)
     
  • CAC 40

    8,045.37
    +28.72 (+0.36%)
     

Saving Lives with Precision Biology

Illumina is the world leader in next-generation sequencing. Adaptive Bio is the leader in immune-driven medicine. Mission Bio pioneered single cell multi-omics for genotype and phenotype. And Endpoint is developing precision therapies for inflammatory illness, sepsis, ARDS and more. Hear from these 4 leaders who are leveraging biology breakthroughs to save lives on a wide range of topics including translating innovation from bench to bedside, aligning incentives with the ecosystem, getting to reimbursement, exploring SPACs and beyond.